Day 3 versus Day 5 biopsy for PGD or PGS

This is one of a series of news items from abstracts of studies presented at the Annual Meeting of the American Society for Reproductive Medicine as complied by Dr. David Meldrum, Scientific Director of Reproductive Partners. We appreciate the enormous amount of work it takes to compile and comment on these abstracts.


In a study reported at ASRM the two

Day 5 embryo biopsy for PGD or PGS less harmful to embryo than Day 3

A study presented at the American Society of Reproductive Medicine Conference in Orlando last week, aimed to compare the safety and efficacy of embryo biopsies conducted for the purposes of screening for genetic disease at day 3 (cleavage stage) versus day 5 (blastocyst stage) of embryonic development. The impact that biopsy has on an embryo's ability to implant and develop …